[go: up one dir, main page]

Alamri et al., 2022 - Google Patents

Era of molecular diagnostics techniques before and after the COVID-19 pandemic

Alamri et al., 2022

View HTML
Document ID
7330682638200537371
Author
Alamri A
Alkhilaiwi F
Ullah Khan N
Publication year
Publication venue
Current Issues in Molecular Biology

External Links

Snippet

Despite the growth of molecular diagnosis from the era of Hippocrates, the emergence of COVID-19 is still remarkable. The previously used molecular techniques were not rapid enough to screen a vast population at home, in offices, and in hospitals. Additionally, these …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Nucleic acid analysis involving immobilisation; Immobilisation characterised by the carrier or coupling agent
    • C12Q1/6837—Nucleic acid analysis involving immobilisation; Immobilisation characterised by the carrier or coupling agent characterised by the use of probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the means of detection
    • C12Q1/6825—Nucleic acid detection involving sensors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures

Similar Documents

Publication Publication Date Title
Yamin et al. Current and future technologies for the detection of antibiotic-resistant bacteria
Kim et al. CRISPR as a Diagnostic Tool
Eftekhari et al. A comprehensive review of detection methods for SARS-CoV-2
Augustine et al. Loop-mediated isothermal amplification (LAMP): a rapid, sensitive, specific, and cost-effective point-of-care test for coronaviruses in the context of COVID-19 pandemic
Klein et al. SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP
Alamri et al. Era of molecular diagnostics techniques before and after the COVID-19 pandemic
Talwar et al. Detection of infectious viruses using CRISPR-Cas12-based assay
Janssen et al. Nucleic acids for ultra-sensitive protein detection
Campuzano et al. Molecular biosensors for electrochemical detection of infectious pathogens in liquid biopsies: current trends and challenges
Zasada et al. Detection of SARS-CoV-2 using reverse transcription helicase dependent amplification and reverse transcription loop-mediated amplification combined with lateral flow assay
Huang et al. Fluorescence Signal-Readout of CRISPR/Cas Biosensors for nucleic acid detection
Azimzadeh et al. CRISPR-powered microfluidics in diagnostics: a review of main applications
Damin et al. CovidArray: a microarray-based assay with high sensitivity for the detection of Sars-Cov-2 in nasopharyngeal swabs
Dorta-Gorrín et al. Detection of SARS-CoV-2 based on nucleic acid amplification tests (NAATs) and its integration into nanomedicine and microfluidic devices as point-of-care testing (POCT)
Huang et al. Microfluidic chip with two-stage isothermal amplification method for highly sensitive parallel detection of SARS-CoV-2 and Measles Virus
Wu et al. Recent progress in single-nucleotide polymorphism biosensors
Huang et al. CRISPR/Cas-based techniques for live-cell imaging and bioanalysis
Attoye et al. Optimisation of an electrochemical DNA sensor for measuring KRAS G12D and G13D point mutations in different tumour types
Zhang et al. Detection of hepatitis B virus M204I mutation by quantum dot-labeled DNA probe
Kwon et al. Advanced CRISPR-Cas effector enzyme-based diagnostics for infectious diseases, including COVID-19
Saxena et al. Development and clinical validation of RT-LAMP-based Lateral-Flow devices and electrochemical sensor for detecting multigene targets in SARS-CoV-2
Nörz et al. Rapid automated screening for SARS-CoV-2 B. 1.617 lineage variants (Delta/Kappa) through a versatile toolset of QPCR-based SNP detection
Sapkota et al. Single-step FRET-based detection of femtomoles DNA
Kumari et al. A novel rolling circle amplification-based detection of SARS-CoV-2 with multi-region padlock hybridization
Erdem et al. Zip nucleic acid-based genomagnetic assay for electrochemical detection of microRNA-34a